Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|February 10, 2015
A multigene array for measurable residual disease detection in AML patients undergoing SCTM Goswami, K S McGowan, K Lu, et al.
Stem Cell Research|December 24, 2014
Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cellsSawa Ito, A John Barrett, Amalia Dutra, et al.
Cytotherapy|October 1, 2015
Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potencyBahey Salem, Samantha Miner, Nancy F Hensel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
In vitro induction of myeloid leukemia-specific CD4 and CD8 T cells by CD40 ligand-activated B cells gene modified to express primary granule proteinsHiroshi Fujiwara, J Joseph Melenhorst, Frank El Ouriaghli, et al.
Oncology Reports|May 9, 1998
Adjuvant therapy for gastric adenocarcinoma with the apoptosis-inducing human monoclonal antibody SC-1: first clinical and histopathological resultsH P Vollmers, U Zimmermann, V Krenn, et al.
Cytotherapy|March 28, 2008
Regulatory T-cell depletion does not prevent emergence of new CD25+ FOXP3+ lymphocytes after antigen stimulation in cultureJ J Melenhorst, P Scheinberg, J Lu, et al.
Leukemia|March 27, 2013
Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplantG Weber, U Gerdemann, I Caruana, et al.
Haematologica|December 3, 2011
Cytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantationJan Joseph Melenhorst, Xin Tian, Dihua Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Contribution of TCR-beta locus and HLA to the shape of the mature human Vbeta repertoireJ Joseph Melenhorst, Matthew D H Lay, David A Price, et al.
Blood|September 25, 2009
The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donorPhillip Scheinberg, Jan J Melenhorst, Jason M Brenchley, et al.
Pageof 5